JPRN-UMIN000031017招募中未知
Weekly nab-Paclitaxel+Carboplatin with Radiotherapy as First Line Therapy in Patients with Advanced Non-Small-Cell Lung Cancer - Weekly nab-Paclitaxel+Carboplatin with Radiotherapy as First Line Therapy in Patients with Advanced Non-Small-Cell Lung Cancer
niversity of Fukui Faculty of Medical Sciences0 个研究点目标入组 25 人开始时间: 2019年1月24日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 25
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 79years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Taxane and CBDCA are contraindicated for administration. 2) A history of severe drug sensitivity. 3) A history of hypersensitivity to albumin. 4)Interstitial pneumonia or pulmonary fibrosis apparent in chest radiography. 5) Active or duplicated cancer with metachronous or simultaneous, multiple cancers. 6) Pleural effusion, drainage and pericardial effusion required drainage. 7) Have serious complications. 8) Patients with peripheral neuropathy of Grade 2 or higher. 9) HBs antigen positive 10) Pregnant women or women who may be pregnant. 11) A man who is willing to conceive. 12) The doctor in charge judged unsuitable for registration of this exam.
研究者
相似试验
尚未招募
2 期
Paclitaxel/Radiotherapy/Cisplatino for cervical cancerUterine Cervical NeoplasmsUterine NeoplasmsGenital Neoplasms, FemaleUterine Cervical DiseasesUterine DiseasesGenital Diseases, FemaleNeoplasmsCervical cancerRPCEC00000239Cancerology State Institute, Colima State Health Service (SSA-Colima), Mexico30
已完成
2 期
Phase2 Trial of Carboplatin-Paclitaxel bi-weekly and Bevacizumab combination therapy for Elderly Patients With Nonsquamous Non-Small-Cell Lung Canceronsquamous Non-Small-Cell Lung CancerJPRN-UMIN000006525Shimane University, School of Medicine23
终止
4 期
Weekly Carboplatin and Taxol with concurrent radiotherapy for locally advanced non small cell lung : Predictive factors for completion of treatment.ACTRN12607000043437South Eastern Illawarra Area Health service45
已完成
2 期
Phase II study of Carboplatin, weekly Paclitaxel and Bevacizumab in elderly patients with advanced non-squamous non-small-cell lung cancer (NEJ 016)non-small cell lung cancerJPRN-UMIN000006622orth East Japan Study Group36
招募中
2 期
Paclitaxel with biweekly cetuximab for platinum- and immune checkpoint inhibitor-refractory head and neck cancerJPRN-jRCTs051200040Kiyota Naomi35